Chapter
Pathogenesis and Diagnosis of Pathologic Cerebral Blood Flow
Impedance Electrical Cardiometry
Near-Infrared Spectroscopy
Amplitude-Integrated EEG (Cerebral Function Monitoring)
Treatment of Hypotension Associated with PDA
Treatment of Hypotension Associated with Other Causes
Impact of Provision of Intensive Care on Systemic and Cerebral Hemodynamics
Summary and Recommendations
Chapter 3 Intraventricular Hemorrhage and White Matter Injury in the Preterm Infant
Periventricular-Intraventricular Hemorrhage
Neuropathology: Relevance to Clinical Findings
Periventricular White Matter Injury Associated with IVH
Postnatal Factors Associated with an Increased Risk
Postnatal Administration of Medications to Reduce Severe IVH
White Matter Injury in the Absence of Hemorrhage
Periventricular Leukomalacia
Intrinsic Vulnerability of the Differentiating Oligodendrocyte
Excitotoxic Injury (Glutamate)
Maternal Fetal Infection and/or Inflammation and White Matter Injury
Clinical Factors Associated with PVL
Intraventricular Hemorrhage
Chapter 4 Posthemorrhagic Hydrocephalus Management Strategies
Question 1: What Measurements of Ventricular Size Are Used in Diagnosis of PHVD?
Question 2: How Can Ventricular Dilation Driven by Cerebrospinal Fluid Under Pressure Be Distinguished from Ventricular Dilation Due to Loss of Periventricular White Matter?
Question 3: How Is Excessive Head Enlargement Defined?
Question 4: How Is Raised Intracranial Pressure Recognized?
Question 5: What Is Infant A’s Prognosis?
Question 6: What Is the Mechanism of PHVD?
Question 7: How Can PHVD Injure White Matter?
Raised Intracranial Pressure, Parenchymal Compression, and Ischemia
Free Radical–Mediated Injury
Proinflammatory Cytokines
Loss of White Matter and Gray Matter
Question 8: What Interventions Have Been Used in PHVD, and Is There Any Evidence That They Improve Outcome?
Ventriculoperitoneal Shunt Surgery
Objectives in Treating PHVD
Repeated Lumbar Punctures or Ventricular Taps
Drug Treatment to Reduce CSF Production
Intraventricular Fibrinolytic Therapy
External Ventricular Drain
Tapping via an Ommaya Reservoir
Choroid Plexus Coagulation
Drainage, Irrigation and Fibrinolytic Therapy
Chapter 5 The Use of Hypothermia to Provide Neuroprotection for Neonatal Hypoxic-Ischemic Brain Injury
Experimental Evidence for the Use of Therapeutic Hypothermia
Implementation of a New Therapy
Temperature Control Before and After Therapeutic Hypothermia
Assessment of Encephalopathy
Is an Amplitude-Integrated Electroencephalography Necessary?
Selective Use of Therapeutic Hypothermia
Future of Therapeutic Hypothermia
Chapter 6 General Supportive Management of the Term Infant with Neonatal Encephalopathy Following Intrapartum Hypoxia-Ischemia
Early Identification of Infants at Highest Risk for Development of Hypoxic-Ischemic Brain Injury
Maintenance of Adequate Perfusion
Control of Blood Glucose Concentration
Prophylactic Phenobarbital
Potential Neuroprotective Strategies Aimed at Ameliorating Secondary Brain Injury
Oxygen Free Radical Inhibitors and Scavengers
Excitatory Amino Acid Antagonists
Potential Role of Magnesium
Chapter 7 Perinatal Stroke
Etiology and Risk Factors for Fetal Stroke
Etiology and Risk Factors for Neonatal Stroke
Gender Effect in the Incidence of Stroke
Spastic Hemiplegic Cerebral Palsy
Role of Magnetic Resonance Imaging
Role of Placental Pathology
Mortality and Long-Term Outcome
Indicators of Long-Term Prognosis
Indicators of Long-Term Prognosis
Chapter 8 Diagnosis and Treatment of Neonatal Seizures
Recognition of Neonatal Seizures
Clinical Seizure Criteria
Multifocal (Fragmentary) Clonic Seizures
Nonepileptic Behaviors of Neonates
Tremulousness or Jitteriness with EEG Correlates
Neonatal Myoclonus without EEG Seizures
Neonatal Dystonia without EEG Seizures
Electrographic Seizure Criteria
Ictal EEG Patterns: A More Reliable Marker for Surface-Recorded Seizure Onset, Duration, and Severity
Seizure Duration and Topography
Subcortical Seizures versus Nonictal Functional Decortication
Brainstem Release Phenomena
Electroclinical Dissociation Suggesting Subcortical Seizures
Variation in the Incidence of Neonatal Seizures Based on Clinical versus EEG Criteria
Seizures in the Clinical Context of Maternal-Fetal-Placental-Neonatal Disease: Developing a Diagnostic Algorithm
Diagnostic Considerations
Emergency Anticonvulsant Drug Treatment
Discontinuation of Drug Use
Single or Synergistic Treatments for General Neonatal Disease States
Treatments That Alter Neurotransmission
Selective Alteration of a Specific Receptor
Chapter 9 Glucose and Perinatal Brain Injury:
Glucose Metabolism in the Fetus and Newborn
Intrauterine Growth Restriction
Cerebral Metabolism of Glucose
Alternative Substrates to Glucose
Symptomatic Versus Asymptomatic Hypoglycemia
Pathophysiology of Hypoglycemia
Cerebral Blood Flow, Glucose Utilization, and Cerebral Energy Metabolism
Cerebral Biochemical Alterations During Hypoglycemia
Hypoglycemia and Brain Damage
Neuroimaging Abnormalities
Hypoglycemia and Hypoxia-Ischemia, Seizures
Chapter 10 Hyperbilirubinemia and the Risk for Brain Injury
Approaches: Strategies for Diagnosis and Treatment
Acute Bilirubin Encephalopathy (Acute Kernicterus)
Diagnosis of Chronic Bilirubin Encephalopathy (Chronic Kernicterus)
Recommendations for Treatment
The New Frontier—Bilirubin-Induced Neurologic Disorders in Preterm Infants: Part of a Kernicterus Spectrum Disorder
Chapter 11 Neonatal Meningitis:
Question 1: What Risk Factors Predispose this Infant to Early-Onset Bacterial Meningitis?
Question 2: Do Infants with Meningitis Have Positive Blood Culture Results?
Question 3: What is the Optimal Evaluation for Possible Late-Onset Sepsis in Preterm Infants in the NICU?
Question 4: What is the Empiric Antimicrobial Choice for Possible Late-Onset Sepsis in the NICU?
Question 5: What is the Treatment of Meningitis in Neonates, and in Particular that due to Gram-Negative Bacilli?
Question 6: Should Other Therapies Be Considered?
Question 7: What is the Duration of Treatment for Meningitis in Neonates?
Question 8: When Should Neuroimaging Be Considered, and What Type of Examination is Recommended?
Question 9: Should Other Adjunctive Therapies Be Provided to an Infant with Meningitis?
Question 10: What If the Infant’s CSF Is Abnormal but Routine Bacterial Cultures of CSF and Blood Are Sterile?
Question 11: What is the Outcome of Meningitis in Neonates?
Chapter 12 Neonatal Herpes Simplex Virus and Congenital Cytomegalovirus Infections
Question 1: When Does Infection Occur?
Question 2: What Are the Risk Factors for Neonatal Infection?
Question 3: What Are the Clinical Manifestations of Neonatal Infection and Disease?
Question 4: What Are the Treatments and Outcomes for HSV and CMV Brain Infections in Neonates?
Question 5: Do All Babies with HSV and CMV Infections Have to Be Treated?
Question 6: What Is the Appropriate Diagnostic Approach to a Baby in Whom HSV or CMV Infection is Suspected?
Question 7. How Should You Monitor the Response to Treatment?
Question 8. What Are the Biggest Gaps in Our Current Understanding of the Natural History, Diagnosis, and Management of these Infections?
Chapter 13 Pain and Stress
Development of Pain Circuits
Developmental Fine-Tuning of Pain Circuits
Influence of Neurotrophins
Influence of Excitatory and Inhibitory Synaptic Connections
Influence of Descending Pathways
Neonatal Pain Reflex Versus Pain Experience
Long-Term Consequences of Early Pain Exposure
Evidence from Rodent Models
Development of the Stress Axis
Corticotropin-Releasing Hormone
Adrenocorticotropic Hormone
Long-Term Consequences of Early Stress Exposure
Effect of Early Stress on Stress Reactivity
Experimental Observations
Effect of Early Stress on Cognition
Effect of Early Stress on Affect and Behavior
Chapter 14 Neonatal Hypotonia and Neuromuscular Disorders
Physical Examination and Assessment of a Hypotonic Child
Differential Anatomic Diagnosis of Hypotonia
Common Neuromuscular Disorders Manifesting Principally with Hypotonia
Anterior Horn Cell and Peripheral Nerve Disorders
Spinal Muscular Atrophies
SMA Type I, or Werdnig-Hoffmann Disease
Congenital Hypomyelinating and Axonal Neuropathies
Disturbances of Neuromuscular Transmission
Transient Neonatal Myasthenia Gravis
Acquired Autoimmune Myasthenia Gravis
Congenital Myasthenic Syndromes
Congenital Muscular Dystrophies
Congenital Muscular Dystrophies Without Structural CNS Anomalies
Merosin-Deficient Classic Congenital Muscular Dystrophy (MDC1A).
Merosin-Positive Classic Congenital Muscular Dystrophy.
Congenital Muscular Dystrophies with Structural CNS Anomalies and/or Mental Retardation
Fukuyama Muscular Dystrophy.
Muscle-Eye-Brain Disease (Santavuori Congenital Muscular Dystrophy).
Congenital Myotonic Dystrophy
Infantile Facioscapulohumeral Muscular Dystrophy
Centronuclear/Myotubular Myopathy
Congenital Fiber Type Disproportion
Other Congenital Myopathies
Acid Maltase Deficiency (Glycogen Storage Disease II)
Infantile Acid Maltase Deficiency (Pompe’s Disease).
Cytochrome c Oxidase Deficiency
Fatal Infantile Myopathy.
Benign Infantile Myopathy.
Fatty Acid Oxidation Defects
Nonlysosomal Glycogenoses
Phosphofructokinase Deficiency
Chapter 15 Amplitude-Integrated EEG and Its Potential Role in Augmenting Management Within the NICU
Assessment of aEEG Background Pattern
Comparison with Standard EEG
Prognostic Value of aEEG in HIE: Noncooled Situation
Prognostic Value of aEEG in HIE: Cooled Situation
Should Subclinical Seizures Be Treated?
aEEG in Other Clinical Conditions
Cranial Ultrasonography for the Evaluation of HIE
MR Techniques in the Evaluation of Perinatal Asphyxia or HIE
Conventional MRI Sequences and Features in HIE
Selective Neuronal Necrosis after Perinatal Asphyxia
Parasagittal Cerebral Injury
Multicystic Encephalomalacia
Diffusion-Weighted Imaging Sequences and Features in HIE
Magnetic Resonance Spectroscopy in HIE
MRI in the Settings of Therapeutic Neonatal Hypothermia
MRI Performed after Hypothermia
Focal and Multifocal Ischemic Brain Necrosis without Asphyxia
MR Techniques in the Evaluation of Focal Ischemic Infarction in the Term Newborn
Traumatic Brain Lesions of the Posterior Fossa
MR Techniques in the Evaluation of Traumatic Brain Injury in the Term Newborn
MR Techniques in the Evaluation of the Preterm Infant
Cranial Ultrasonography in the Preterm Infant
Conventional MRI in the Preterm Infant
DWI in the Preterm Infant
MRS in the Preterm Infant
Advanced Quantitative MRI with Image Analysis Tools
Chapter 17 Long-Term Follow-Up of Very Low-Birth-Weight Infants
Outcome: Cerebral Palsy and Other Neurologic or Sensory Sequelae
The 18- to 24-Month-Old Child
Early Developmental Assessments
Bayley Scales of Infant Development II
Important Lessons for Diagnosis and Intervention
The 3- to 6-Year-Old Child
Important Lessons for Diagnosis and Intervention
Important Lessons for Diagnosis and Intervention
The Adolescent and Young Adult
Important Lessons for Diagnosis and Intervention